NEUREN PHARMACEUTICALS LIMITED - Charts / Financials

3.11%

$19.00

Market Cap $2.399B

Healthcare Biotechnology

Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing... Neuren Pharmaceuticals Limited is an Australia-based biopharmaceutical company developing therapies for neurodevelopmental disorders. The Company is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. The Company’s product DAYBUE (trofinetide) is used to treat Rett syndrome in adults and pediatric patients two years of age and older. The United States (US) Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have both granted orphan drug designation to the Company for trofinetide in Fragile X syndrome. Its second product NNZ-2591 is in phase II clinical trials in Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome and Prader-Willi syndrome. The Company has granted an exclusive worldwide license to Acadia Pharmaceuticals Inc. for the development and commercialization of NNZ-259 for Rett syndrome and Fragile X syndrome.More

MEMPHASYS LIMITED

Many are concerned about global falling birthrates. This diverse stock has solutions. Here, then, one can’t afford to miss perusing what ASX-listed fertility tech healthcare smallcap Memphasys Ltd (ASX:MEM) can offer the world.

REFRESH

Last update - 15.59pm 03/09/2025 (20 minute delay)

Day
Open	$19.63		Day High	$19.80		Day Low	$18.90
Daily Volume	726610

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
2	$18.90	1082		1	$19.01	1000

Directors & Senior Management

Mr. Jonathan Charles Pilcher	Chief Executive Officer, Managing Director, Executive Director
Ms. Lauren Frazer	Chief Financial Officer, Company Secretary
Dr. Clive Blower	Chief Operating Officer
Mr. Larry Glass	Chief Science Officer
Ms. Liza Squires	Chief Medical Officer
Mr. Gerry Zhao	Chief Business Officer
Mr. Patrick Donald Davies	Non-Executive Independent Chairman of the Board
Ms. Dianne Angus	Non-Executive Independent Director
Mr. Joseph Basile	Non-Executive Independent Director
Dr. Jenny Lee Harry	Non-Executive Independent Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $19.00		Change -0.610(3.11%)		Mkt cap ! $2.399B

Open	High	Low	Value	Volume
$19.63	$19.80	$18.90	$14.00M	726.6K

Buyers (Bids)

No.	Vol.	Price($)
2	1082	$18.90

Sellers (Offers)

Price($)	Vol.	No.
$19.01	1000	1

View Market Depth

No.	Vol.	Price($)
2	1082	18.900
1	5000	18.890
2	11770	18.880
2	1197	18.870
1	1000	18.850

Price($)	Vol.	No.
19.010	1000	1
19.040	1008	2
19.190	106	1
19.370	3000	1
19.390	1000	1

Last trade - 16.10pm 03/09/2025 (20 minute delay)


Last $18.93		Change -0.610 ( 3.73 %)
Open	High	Low	Volume
$19.56	$19.78	$18.90	202021
Last updated 15.59pm 03/09/2025 ?

NEU (ASX) Chart

NEUREN PHARMACEUTICALS LIMITED - Charts / Financials

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories